Vnitr Lek 2015, 61(10):878-881

Autoimmune thyroiditis and thyroid cancer

Jan Krátký*, Jan Jiskra
III. interní klinika 1. LF UK a VFN Praha, přednosta prof. MUDr. Štěpán Svačina, DrSc., MBA

Association between autoimmune thyroiditis (CLT) and thyroid cancer remains not clear. Although both diseases often occur simultaneously in histological samples, it is not yet clear whether CLT can be regarded as a risk factor for thyroid malignancy. This review focus on the known epidemiological and molecular genetics links between both diseases. Most studies have shown a significant association between thyroid cancer and positive antibodies to thyroglobulin and histological evidence of CLT, as well. Both disorders share some risk factors (greater incidence in women, in areas with adequate supply of iodine and in patients after radiotherapy of the neck) and molecular genetics linkage. For example: RET/PTC rearrangements could be more often found in carcinomas associated with CLT, but this mutation could be found in benign lesions such as CLT, as well. CLT seems to be a positive prognostic factor in patients with differentiated thyroid cancer. It is associated with less invasive forms of tumor, lower occurrence of infiltrated lymphatic nodes and a lower risk of recurrence.

Keywords: antithyroid antibodies; autoimmune thyroiditis; thyroid cancer; thyroid nodule

Received: August 19, 2015; Accepted: September 25, 2015; Published: October 1, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Krátký J, Jiskra J. Autoimmune thyroiditis and thyroid cancer. Vnitr Lek. 2015;61(10):878-881.
Download citation

References

  1. Cooper DS, Doherty GM, Haugen BR et al. Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2009; 19(11): 1167-214. Go to original source... Go to PubMed...
  2. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 2006; 295(18): 2164-2167. Go to original source... Go to PubMed...
  3. Kamran SC, Marqusee E, Kim MI et al. Thyroid nodule size and prediction of cancer. J Clin Endocrinol Metab 2013; 98(2): 564-570. Go to original source... Go to PubMed...
  4. Jacobson DL, Gange SJ, Rose NR et al. Epidemiology and Estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 1997; 84(3): 223-243. Go to original source... Go to PubMed...
  5. McLeod DS, Cooper DS. The incidence and prevalence of thyroid autoimmunity. Endocrine 2012; 42(2): 252-265. Go to original source... Go to PubMed...
  6. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001; 357(9255): 539-545. Go to original source... Go to PubMed...
  7. Dailey ME, Lindsay S, Skahen R. Relation of thyroid neoplasms Hashimoto's disease of the thyroid gland. AMA Arch Surg 1955; 70(2): 291-297. Go to original source... Go to PubMed...
  8. Lee JH, Kim Y, Choi JW et al. The Association Between papillary thyroid carcinoma and histologically proven Hashimoto's thyroiditis: a meta-analysis. Eur J Endocrinol 2013; 168(3): 343-349. Go to original source... Go to PubMed...
  9. Liu X, Zhu L, Cui D et al. Histologically Confirmed Coexistence of Hashimoto's thyroiditis with Different Stages of Papillary Thyroid Carcinoma in a Cohort Consecutive Chinese. Int J Endocrinol 2014; 2014:769294. Dostupné z DOI: <http://dx.doi.org/10.1155/2014/769294>. Go to original source... Go to PubMed...
  10. Shu S, Plautz GE, Krauss JC et al. Tumor immunology. JAMA 1997; 278(22): 1972-1981. Go to original source...
  11. Azizi G, Keller JM, Lewis M et al. Association of Hashimoto's thyroiditis with thyroid cancer. Endocr Relat Cancer 2014; 21(6): 845-852. Go to original source... Go to PubMed...
  12. Kim EC, Lim DJ, Baek KH et al. Thyroglobulin antibody is associated with Increased cancer risk in thyroid nodules. Thyroid 2010; 20(8): 885-891. Go to original source... Go to PubMed...
  13. Boi F, Lai ML, Marziano B et al. High prevalence of suspicious cytology in thyroid nodules associated with positive thyroid autoantibodies. Eur J Endocrinol. 2005; 153(5): 637-642. Go to original source... Go to PubMed...
  14. Fiore E, Rago T, Scutari M et al. Papillary thyroid cancer, although Strongly associated with lymphocytic infiltration on histology, is only weakly predicted by serum thyroid auto-antibodies in patients with nodular thyroid diseases. J Endocrinol Invest 2009; 32(4): 344-351. Go to original source... Go to PubMed...
  15. Loh KC, Greenspan FS, Dong F et al. Influence of lymphocytic thyroiditis on the prognostic outcome of Patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 1999; 84(2): 458-463. Go to original source... Go to PubMed...
  16. Souza SL, Montalli da Assumpção LV, Ward LS. Impact of previous thyroid autoimmune diseases on prognosis of Patients with well-Differentiated thyroid cancer. Thyroid 2003; 13(5): 491-495. Go to original source... Go to PubMed...
  17. Tam AA, Kaya C, Kiliç FB et al. Thyroid nodules and thyroid cancer in Graves' disease. Arq Bras Endocrinol Metabol 2014; 58(9): 933-938. Go to original source... Go to PubMed...
  18. Belfiore A, Russo D, Vigneri R et al. Graves' disease, thyroid nodules and thyroid cancer. Clin Endocrinol (Oxf) 2001; 55(6): 711-718. Go to original source... Go to PubMed...
  19. Cunha LL, Ferreira RC, Marcello MA et al. Clinical and pathological implications of concurrent disorders and Autoimmune thyroid papillary thyroid cancer. J Thyroid Res 2011; 2011: 387062. Dostupné z DOI: <http://dx.doi.org/10.4061/2011/387062>. Go to original source... Go to PubMed...
  20. Weetman AP. Cellular immune responses in autoimmune thyroid disease. Clin Endocrinol (Oxf) 2004; 61(4): 405-413. Go to original source... Go to PubMed...
  21. Pacifico F, Leonardi A. Role of NF-κB in the thyroid cancer. Mol Cell Endocrinol 2010; 321(1): 29-35. Go to original source... Go to PubMed...
  22. Muzza M, Degl'innocenti D, Colombo C et al. The tight Relationship between papillary thyroid cancer, autoimmunity and inflammation: clinical and molecular studies. Clin Endocrinol (Oxf) 2010; 72(5): 702-708. Go to original source... Go to PubMed...
  23. Guarino V, Castellon MD, Avilla E et al. Thyroid Cancer and Inflammation. Mol Cell Endocrinol 2010; 321(1): 94-102. Go to original source... Go to PubMed...
  24. Kim SK, Song KH, Lim SO et al. Clinical and pathological features and the BRAF mutation in patients with papillary thyroid carcinoma with and without Hashimoto thyroiditis. Thyroid 2009; 19(2): 137-141. Go to original source... Go to PubMed...
  25. Weber F. Lymphocytes and thyroid cancer: more to it Than Meets the Eye? Endocr Relat Cancer 2014; 21(3): C1-C5. Dostupné z DOI: <http://dx.doi.org/10.1530/ERC-14-0229>. Go to original source... Go to PubMed...
  26. Cunha LL, Marcello MA, Ward LS. The role of the inflammatory microenvironment in thyroid carcinogenesis. Endocr Relat Cancer 2014; 21(3): R85-R103. Dostupné z DOI: <http://dx.doi.org/10.1530/ERC-13-0431>. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.